TrialThe Journal of clinical psychiatry2015

Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder.

Edna B Foa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.